About: http://webisa.webdatacommons.org/347949914

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Vemurafenib: marketed as Zelboraf, the drug is a B-Raf enzyme inhibitor developed by Plexxicon, which has become part of Daiichi-Sankyo) and Genentech.
http://www.w3.org/ns/prov#wasQuotedFrom	prohostbiotech.com